István Láng
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
-
- Advanced Breast Cancer Therapies
- Silymarin and Mushroom Poisoning
Papers in
-
- Breast Cancer Treatment Studies 13
- Immunology 13
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
- Co-authors
- Katalin Boér (5 shared papers)Sophia Randolph (4 shared papers)Richard S. Finn (4 shared papers)John Paul Crown (4 shared papers)Dennis J. Slamon (3 shared papers)Xin Huang (3 shared papers)Tamás Pintér (3 shared papers)Johannes Ettl (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (7 papers)The Lancet Oncology (6 papers)European Journal of Cancer (4 papers)Immunopharmacology (3 papers)
- Partner nations
- HungaryUnited StatesBelgium
In The Last Decade
István Láng
94 papers receiving 5.8k citations
István Láng's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 1.6k
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 832
- Drug Discovery 1
- Pharmacology 64
Countries citing papers authored by István Láng
This map shows the geographic impact of István Láng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Láng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Láng more than expected).
Fields of papers citing papers by István Láng
This network shows the impact of papers produced by István Láng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Láng. The network helps show where István Láng may publish in the future.
Co-authors
The 25 scholars most cited alongside István Láng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study Hit paper breakdown → | 2014 | 1593 |
| 2 | 2014 | 559 | |
| 3 | 2017 | 469 | |
| 4 | 2014 | 416 | |
| 5 | 2018 | 404 | |
| 6 | 2011 | 310 | |
| 7 | 2016 | 152 | |
| 8 | 2016 | 135 | |
| 9 | 2011 | 117 | |
| 10 | 2016 | 117 | |
| 11 | 2017 | 106 | |
| 12 | 2018 | 105 | |
| 13 | 2017 | 102 | |
| 14 | 2019 | 91 | |
| 15 | [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. | 1989 | 88 |
| 16 | 2011 | 70 | |
| 17 | 2016 | 66 | |
| 18 | 2019 | 63 | |
| 19 | 2021 | 63 | |
| 20 | Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme. | 1991 | 58 |
About István Láng
István Láng is a scholar working on Cancer Research, Immunology, Pulmonary and Respiratory Medicine, Oncology and Nephrology, having authored 97 papers that have together received 6.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Silymarin and Mushroom Poisoning (9 papers), Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (8 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers), Inflammatory mediators and NSAID effects (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (1.4k citations), Oncology (832 citations), Drug Discovery (1 citation) and Pharmacology (64 citations). István Láng has collaborated with scholars based in Hungary, United States and Belgium. Frequent co-authors include Katalin Boér, Sophia Randolph, Richard S. Finn, John Paul Crown, Dennis J. Slamon, Xin Huang, Tamás Pintér, Johannes Ettl, Marcus Schmidt and Sindy T. Kim. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Lancet Oncology, European Journal of Cancer and Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.